Corina U Greven1, Janita Bralten2, Maarten Mennes3, Laurence O'Dwyer3, Kimm J E van Hulzen4, Nanda Rommelse5, Lizanne J S Schweren6, Pieter J Hoekstra6, Catharina A Hartman6, Dirk Heslenfeld7, Jaap Oosterlaan7, Stephen V Faraone8, Barbara Franke9, Marcel P Zwiers10, Alejandro Arias-Vasquez11, Jan K Buitelaar12. 1. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands2Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands3Social, Genetic. 2. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. 3. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands. 4. Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. 5. Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands5Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands. 6. Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 7. Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, the Netherlands. 8. Department of Psychiatry, State University of New York Upstate Medical University, Syracuse. 9. Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands5Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands. 10. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands10Donders Institute for Brain, Cognition, and Behaviour, Radboud University, Nijmegen, the Netherlands. 11. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands5Department. 12. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands2Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands.
Abstract
IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelopmental disorder. It has been linked to reductions in total brain volume and subcortical abnormalities. However, owing to heterogeneity within and between studies and limited sample sizes, findings on the neuroanatomical substrates of ADHD have shown considerable variability. Moreover, it remains unclear whether neuroanatomical alterations linked to ADHD are also present in the unaffected siblings of those with ADHD. OBJECTIVE: To examine whether ADHD is linked to alterations in whole-brain and subcortical volumes and to study familial underpinnings of brain volumetric alterations in ADHD. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we included participants from the large and carefully phenotyped Dutch NeuroIMAGE sample (collected from September 2009-December 2012) consisting of 307 participants with ADHD, 169 of their unaffected siblings, and 196 typically developing control individuals (mean age, 17.21 years; age range, 8-30 years). MAIN OUTCOMES AND MEASURES: Whole-brain volumes (total brain and gray and white matter volumes) and volumes of subcortical regions (nucleus accumbens, amygdala, caudate nucleus, globus pallidus, hippocampus, putamen, thalamus, and brainstem) were derived from structural magnetic resonance imaging scans using automated tissue segmentation. RESULTS: Regression analyses revealed that relative to control individuals, participants with ADHD had a 2.5% smaller total brain (β = -31.92; 95% CI, -52.69 to -11.16; P = .0027) and a 3% smaller total gray matter volume (β = -22.51; 95% CI, -35.07 to -9.96; P = .0005), while total white matter volume was unaltered (β = -10.10; 95% CI, -20.73 to 0.53; P = .06). Unaffected siblings had total brain and total gray matter volumes intermediate to participants with ADHD and control individuals. Significant age-by-diagnosis interactions showed that older age was linked to smaller caudate (P < .001) and putamen (P = .01) volumes (both corrected for total brain volume) in control individuals, whereas age was unrelated to these volumes in participants with ADHD and their unaffected siblings. Attention-deficit/hyperactivity disorder was not significantly related to the other subcortical volumes. CONCLUSIONS AND RELEVANCE: Global differences in gray matter volume may be due to alterations in the general mechanisms underlying normal brain development in ADHD. The age-by-diagnosis interaction in the caudate and putamen supports the relevance of different brain developmental trajectories in participants with ADHD vs control individuals and supports the role of subcortical basal ganglia alterations in the pathophysiology of ADHD. Alterations in total gray matter and caudate and putamen volumes in unaffected siblings suggest that these volumes are linked to familial risk for ADHD.
IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelopmental disorder. It has been linked to reductions in total brain volume and subcortical abnormalities. However, owing to heterogeneity within and between studies and limited sample sizes, findings on the neuroanatomical substrates of ADHD have shown considerable variability. Moreover, it remains unclear whether neuroanatomical alterations linked to ADHD are also present in the unaffected siblings of those with ADHD. OBJECTIVE: To examine whether ADHD is linked to alterations in whole-brain and subcortical volumes and to study familial underpinnings of brain volumetric alterations in ADHD. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we included participants from the large and carefully phenotyped Dutch NeuroIMAGE sample (collected from September 2009-December 2012) consisting of 307 participants with ADHD, 169 of their unaffected siblings, and 196 typically developing control individuals (mean age, 17.21 years; age range, 8-30 years). MAIN OUTCOMES AND MEASURES: Whole-brain volumes (total brain and gray and white matter volumes) and volumes of subcortical regions (nucleus accumbens, amygdala, caudate nucleus, globus pallidus, hippocampus, putamen, thalamus, and brainstem) were derived from structural magnetic resonance imaging scans using automated tissue segmentation. RESULTS: Regression analyses revealed that relative to control individuals, participants with ADHD had a 2.5% smaller total brain (β = -31.92; 95% CI, -52.69 to -11.16; P = .0027) and a 3% smaller total gray matter volume (β = -22.51; 95% CI, -35.07 to -9.96; P = .0005), while total white matter volume was unaltered (β = -10.10; 95% CI, -20.73 to 0.53; P = .06). Unaffected siblings had total brain and total gray matter volumes intermediate to participants with ADHD and control individuals. Significant age-by-diagnosis interactions showed that older age was linked to smaller caudate (P < .001) and putamen (P = .01) volumes (both corrected for total brain volume) in control individuals, whereas age was unrelated to these volumes in participants with ADHD and their unaffected siblings. Attention-deficit/hyperactivity disorder was not significantly related to the other subcortical volumes. CONCLUSIONS AND RELEVANCE: Global differences in gray matter volume may be due to alterations in the general mechanisms underlying normal brain development in ADHD. The age-by-diagnosis interaction in the caudate and putamen supports the relevance of different brain developmental trajectories in participants with ADHD vs control individuals and supports the role of subcortical basal ganglia alterations in the pathophysiology of ADHD. Alterations in total gray matter and caudate and putamen volumes in unaffected siblings suggest that these volumes are linked to familial risk for ADHD.
Authors: Roza Vlasova; Niharika Gajawelli; Yalin Wang; Holly Dirks; Douglas Dean; Jonathan O'Muircheartaigh; Yi Lao; James Yoon; Marvin D Nelson; Sean Deoni; Natasha Lepore Journal: Proc SPIE Int Soc Opt Eng Date: 2017-01-26
Authors: Karen E Seymour; Xiaoying Tang; Deana Crocetti; Stewart H Mostofsky; Michael I Miller; Keri S Rosch Journal: Psychiatry Res Neuroimaging Date: 2017-01-06 Impact factor: 2.376
Authors: Lisa A Jacobson; Deana Crocetti; Benjamin Dirlikov; Keith Slifer; Martha Bridge Denckla; Stewart H Mostofsky; E Mark Mahone Journal: J Int Neuropsychol Soc Date: 2018-03-26 Impact factor: 2.892
Authors: Marieke Klein; Raymond K Walters; Ditte Demontis; Jason L Stein; Derrek P Hibar; Hieab H Adams; Janita Bralten; Nina Roth Mota; Russell Schachar; Edmund Sonuga-Barke; Manuel Mattheisen; Benjamin M Neale; Paul M Thompson; Sarah E Medland; Anders D Børglum; Stephen V Faraone; Alejandro Arias-Vasquez; Barbara Franke Journal: Am J Psychiatry Date: 2019-03-01 Impact factor: 18.112
Authors: Thomas Wolfers; Alberto Llera Arenas; A Marten H Onnink; Janneke Dammers; Martine Hoogman; Marcel P Zwiers; Jan K Buitelaar; Barbara Franke; Andre F Marquand; Christian F Beckmann Journal: J Psychiatry Neurosci Date: 2017-11 Impact factor: 6.186
Authors: Emily M Johnson; Alexandra D Ishak; Paige E Naylor; David A Stevenson; Allan L Reiss; Tamar Green Journal: Cereb Cortex Date: 2019-07-05 Impact factor: 5.357
Authors: Yuliya N Yoncheva; Krishna Somandepalli; Philip T Reiss; Clare Kelly; Adriana Di Martino; Mariana Lazar; Juan Zhou; Michael P Milham; F Xavier Castellanos Journal: J Am Acad Child Adolesc Psychiatry Date: 2015-11-26 Impact factor: 8.829
Authors: Michael A Mooney; Priya Bhatt; Robert J M Hermosillo; Peter Ryabinin; Molly Nikolas; Stephen V Faraone; Damien A Fair; Beth Wilmot; Joel T Nigg Journal: Psychol Med Date: 2020-01-24 Impact factor: 7.723